Interleukin-12 Uses, Dosage, Side Effects and more

Interleukin-12 is under investigation in clinical trial NCT01468896 (Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery).

Attribute	Details
Trade Name	Interleukin-12
Generic	Edodekin alfa
Edodekin alfa Other Names	Edodekin alfa, Human il-12 (recombinant), Interleukin 12 (human), Interleukin-12, human, Recombinant Human Interleukin-12, Recombinant interleukin-12
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph